How Much Does Eliquis Cost in 2026?
Eliquis (apixaban) is a twice-daily blood thinner used for atrial fibrillation and for treating and preventing blood clots. Medicare's negotiated price took effect on January 1, 2026: $231 for a 30-day supply, 56% below the $521 list price CMS used as the comparison. Unlike most write-ups of that number, this page is about the three prices Eliquis now has at the same time, and which one applies to you.
- Medicare's negotiated price for Eliquis is $231 per 30-day supply, in effect since January 1, 2026. It is what Medicare and your Part D plan pay, not your copay.
- The manufacturers' own cash price, $346 a month through Eliquis 360 Support, is higher than the price Medicare negotiated. If you have Part D, buying cash is the more expensive route.
- The main Eliquis patent expired in November 2026, but patent settlements keep generic apixaban off US pharmacy shelves until April 1, 2028. A patent expiring is not a generic arriving.
- Whatever your plan charges, your total Medicare Part D out-of-pocket is capped at $2,100 in 2026, after which covered drugs cost you nothing for the rest of the year.
Eliquis Has Three Different Prices Right Now
All figures are for a 30-day supply at the standard 5 mg twice-daily dose. Which price applies to you depends entirely on what coverage you have.
| Price | 30 days |
|---|---|
| Medicare negotiated price | $231 |
| Manufacturer cash price | $346 |
| List price | $521 to $606 |
| What Part D members typically paid | ~$47 median |
| Commercial insurance with the copay card | as low as $10 |
The cash price is higher than the negotiated price, and that catches people out
In 2025 the manufacturers launched a direct-to-patient option at $346 a month, marketed as a roughly 43% discount off list. It is a genuine discount if you are uninsured. But it sits 50% above the $231 Medicare negotiated for the same 30 days, so for anyone with Part D it is the worse deal, and Part D members are not eligible for it anyway.
There is a second reason to be careful about paying cash when you have Part D: money you spend outside your plan does not count toward your Part D deductible or toward the $2,100 out-of-pocket cap. Paying cash can therefore cost you more now and push back the point where your drugs become free for the rest of the year.
What Medicare's Negotiated Price Does, and Does Not, Change
The headline number is not your copay.
$231 is the maximum fair price, the amount Medicare and your Part D plan pay for a 30-day supply. What you are charged at the counter is still set by your plan's tier and cost-sharing rules.
It helps you directly if you pay coinsurance
Non-preferred brand tiers often charge a percentage rather than a flat copay. Roughly 13% of Part D members whose plans covered Eliquis had it on a non-preferred tier, with about 1 in 10 facing 50% coinsurance. Half of $231 is a very different bill from half of $521.
It may not change a flat copay
If your plan charges a fixed dollar copay on that tier, your copay can stay the same even though your plan is paying far less. The saving then shows up in the program's costs rather than on your receipt.
It changes how fast you hit the cap
Your spending counts toward the $2,100 annual Part D out-of-pocket cap in 2026. A cheaper drug means a smaller share each month, so you may reach the cap later in the year or not at all, and the year-end picture differs from past years.
It does not change coverage rules
A negotiated price does not force a plan to cover Eliquis, drop prior authorization, or change its tier. Plans still set their own formularies, so check yours rather than assuming the new price reaches you.
Because tiers and cost-sharing vary so much between plans, the only way to know your real cost is to check Eliquis against each plan's formulary. If you would rather have that done for you, our Find My Medicare Plan service checks your specific drugs against the plans available to you for a flat $99.
When Does Generic Eliquis Arrive?
This is where most of the confusion sits, because two different dates get mixed together.
- The patent on apixaban itself, the active ingredient, expired on November 21, 2026, with pediatric exclusivity running to May 21, 2027.
- Generic apixaban still cannot be sold in US pharmacies until April 1, 2028. Several manufacturers already hold FDA tentative approval, meaning the FDA has confirmed their product is equivalent, but patent settlements and a separate formulation patent keep it off the shelf.
So if you have read that the Eliquis patent has expired and expected a cheap generic at your pharmacy, that is why it is not there. For now the negotiated $231 is the structural price reduction, not a generic.
Does Insurance Cover Eliquis?
Almost always, but check the tier
Eliquis is covered by essentially every Medicare Part D plan and nearly all commercial plans, usually on a preferred brand tier. The tier, not the coverage, is what decides your cost, and the same drug can sit on different tiers in two plans sold in the same ZIP code.
If you are denied or moved a tier
Plans can require prior authorization or step therapy, and they can move a drug to a worse tier at renewal. You have formal appeal rights, and your prescriber can submit a letter of medical necessity. See how to appeal an insurance denial and what to do when a plan drops your drug.
How to Pay Less
On Medicare, check Extra Help first
With the Extra Help (Low Income Subsidy) program, brand-drug copays are capped at a few dollars a month rather than $47 or a percentage of $231. The income limits are higher than most people assume, and it is the single largest lever available to a Part D member on an expensive brand drug.
Compare the tier, not the premium, at open enrollment
A plan with a low premium that puts Eliquis on a non-preferred tier with 50% coinsurance can cost you far more over a year than a higher-premium plan that keeps it preferred. Check Eliquis specifically on each plan's formulary, and re-check every year, because tiers move.
Spread the cost with the Medicare Prescription Payment Plan
If your share lands early in the year, this program spreads your Part D out-of-pocket evenly across the twelve months instead of front-loading it. It does not reduce the total, but it prevents the January and February spike that makes people skip doses. You opt in through your plan.
On commercial insurance, use the copay card
The manufacturer card can bring a commercial copay to roughly $10 a month. It is barred by law from use with Medicare, Medicaid, or other federal coverage, so it is not an option once you are on Part D.
If you are uninsured, compare the cash routes before you commit
Eliquis 360 Support is $346 a month with no income test, and ordinary pharmacy discount cards land in a similar range, so check both rather than assuming the manufacturer route is cheapest. If your income is modest, also check whether you qualify for Medicaid or for the manufacturer's patient assistance program, which can be $0.
Push back on a bill you have already received
If you were charged more than you expected, or a pharmacy claim was processed wrong, CareRoute Bill Defense reviews and disputes medical bills, with no fee unless we save you money.
Not sure which plan covers Eliquis best?
For a flat $99, we research the Medicare plans available to you and check them against your specific drugs and doctors, then hand you a clear comparison. We are independent, sell no insurance, and take no commissions.
Frequently Asked Questions
How much does Eliquis cost without insurance?
The manufacturers sell Eliquis directly to cash-paying patients for $346 a month through Eliquis 360 Support, with no income requirement, which is about 43% below the roughly $606 published list price. Ordinary pharmacy discount cards land in a similar range, so it is worth comparing both. If you have Medicare Part D you are not eligible for the direct program, and you should not want it anyway: Medicare's negotiated price of $231 is lower.
What is Medicare's negotiated price for Eliquis?
Medicare negotiated a maximum fair price of $231 for a 30-day supply of Eliquis, effective January 1, 2026. That is 56% below the $521 list price CMS used as the comparison. Eliquis was one of the first ten drugs in the Medicare Drug Price Negotiation Program, selected because it was the highest-spending Part D drug without generic competition. The price applies automatically at the pharmacy for Part D members.
Will the negotiated price lower what I actually pay for Eliquis?
It can, but it is not your new copay. The maximum fair price is what Medicare and your Part D plan pay the pharmacy, not automatically what you are charged. If your plan charges coinsurance, a percentage of the drug price, a lower negotiated price lowers your share directly, and about 1 in 10 Part D members whose plan covered Eliquis faced 50% coinsurance on a non-preferred tier. If your plan charges a flat copay for that tier, your copay may not change at all. In 2023 the median Part D copay for Eliquis was about $47 a month. Either way, your total Part D out-of-pocket is capped at $2,100 in 2026.
Is there a generic for Eliquis yet?
No. The patent on apixaban, the active ingredient, expired on November 21, 2026, with pediatric exclusivity running to May 21, 2027, but generic apixaban cannot be sold in US pharmacies until April 1, 2028 under patent settlements upheld on appeal. Several manufacturers already hold FDA tentative approval, which means their version has been reviewed and found equivalent but cannot be marketed yet. A separate formulation patent runs to 2031 and is still being litigated. An expired patent is not the same as an available generic.
Is Eliquis or Xarelto cheaper on Medicare?
Both were in the first round of Medicare negotiation and both prices took effect January 1, 2026. Xarelto's negotiated price is $197 for a 30-day supply against Eliquis at $231, so Xarelto is lower at the Medicare level. That does not mean it is cheaper for you, because your copay depends on your own plan's tier for each drug, and the two can sit on different tiers in the same plan. They are also not interchangeable: Eliquis is taken twice daily and Xarelto once daily, and the clinical choice belongs with your prescriber, not with a price table. Check both on your plan's formulary before raising it with your doctor.
Can I use the Eliquis copay card with Medicare?
No. The manufacturer copay card, which can bring a commercial copay to roughly $10 a month, is barred by federal law from use with Medicare, Medicaid, or any other government coverage. On Medicare the equivalents are Extra Help (the Low Income Subsidy), independent charity foundation grants when their funds are open, and the Medicare Prescription Payment Plan, which spreads your costs across the year rather than reducing them.
Related
Sources
- CMS, Medicare Drug Price Negotiation Program: Negotiated Prices for Initial Price Applicability Year 2026 (maximum fair price and list-price comparison)
- CMS / Medicare.gov (Part D out-of-pocket cap, $2,100 in 2026, and the $615 maximum deductible)
- KFF, "Eliquis's New Lower Direct-to-Consumer Price is Still Higher Than Medicare's Negotiated Price" ($346 direct price, $47 median 2023 Part D copay, non-preferred tier cost sharing)
- Bristol Myers Squibb / Pfizer published list price and Eliquis 360 Support program terms
- FDA Orange Book and reported patent settlements (apixaban patent expiry and the April 1, 2028 generic entry date)
Prices are national figures for a 30-day supply at the standard dose and vary by pharmacy, dose, and plan. This page is educational and is not medical or financial advice. Eliquis is a blood thinner and stopping or switching it without your prescriber's guidance carries serious risk. Last updated November 20, 2026.